TCR repertoire, clonal dominance, and pulmonary trafficking of mycobacterium-specific CD4+ and CD8+ T effector cells in immunity against tuberculosis.
Clonal responses of Mycobacterium tuberculosis-specific CD4(+) or CD8(+) T effector cells producing antituberculosis cytokine IFN-γ in the context of immune protection against tuberculosis remain poorly characterized in humans. Utilizing decade-long TCR expertise, we previously developed a useful method to isolate clonotypic TCR sequences from Ag-specific IFN-γ-producing T cells and to specifically measure clonotypic TCR frequencies in the T cell pool. In this study, we investigated TCR Vβ repertoires/CDR3 usage, clonal expansion or dominance, and pulmonary trafficking or accumulation for purified protein deritative (PPD)-specific T effector cells producing IFN-γ during bacillus Calmette-Guérin (BCG) vaccination and subsequent M. tuberculosis challenge of macaques. We found that while PPD-specific CD4(+) and CD8(+) T effector clones employed diverse TCR Vβ repertoires, 30-33% of IFN-γ(+)CD4(+) T cell clones from three M. tuberculosis-infected macaques expressed TCR bearing a conserved residue leucine in CDR3. Many Ag-specific IFN-γ(+) CD4(+) and few CD8(+) T effector cells emerged as dominant clones during mycobacterial infections and underwent major recall expansion after pulmonary M. tuberculosis infection of BCG-vaccinated macaques. PPD-specific T cell clones readily trafficked to the airway or lung after BCG vaccination or M. tuberculosis infection, and some of them continuously accumulated in lungs during M. tuberculosis infection even after they became undetectable in the circulation. Importantly, remarkable recall expansion and pulmonary accumulation of T effector cells coincided with BCG-induced protection against tuberculosis. Thus, rapid clonal expansion and pulmonary accumulation of Ag-specific T effector cells appear to be one of the immune mechanisms underlying immunity against tuberculosis.
Du
George
G
Department of Microbiology and Immunology, Center for Primate Biomedical Research, University of Illinois College of Medicine, Chicago, IL 60612, USA.
Chen
Crystal Y
CY
Shen
Yun
Y
Qiu
Liyou
L
Huang
Dan
D
Wang
Richard
R
Chen
Zheng W
ZW
D000595:Amino Acid Sequence; D000818:Animals; D001500:BCG Vaccine / Q000276:immunology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D002469:Cell Separation; D002634:Chemotaxis, Leukocyte / Q000276:immunology*; D005434:Flow Cytometry; D019672:Genes, T-Cell Receptor; D008253:Macaca mulatta; D008969:Molecular Sequence Data; D009169:Mycobacterium tuberculosis / Q000276:immunology; D011948:Receptors, Antigen, T-Cell / Q000235:genetics*; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods; D014397:Tuberculosis, Pulmonary / Q000235:genetics / Q000276:immunology* / Q000517:prevention & control
D001500:BCG Vaccine; D011948:Receptors, Antigen, T-Cell
Tuberculosis (Edinb). 2003;83(1-3):98-106
12758197
Nat Rev Immunol. 2001 Oct;1(1):20-30
11905811
J Virol. 2004 Dec;78(24):14023-32
15564509
Curr Opin Microbiol. 2004 Feb;7(1):58-61
15036141
Infect Immun. 1995 Apr;63(4):1235-40
7890378
Immunol Rev. 2008 Dec;226:191-204
19161425
J Immunol. 2007 Jul 15;179(2):1331-9
17617626
J Infect Dis. 1990 Jul;162(1):8-12
1972384
Clin Exp Immunol. 2003 Aug;133(2):182-92
12869023
J Infect Dis. 2007 Aug 15;196 Suppl 1:S86-107
17624830
Lancet. 1993 Jul 17;342(8864):143-6
8101257
J Immunol Methods. 2006 Jan 20;308(1-2):19-35
16403511
PLoS One. 2009 Sep 04;4(9):e6905
19730727
Infect Immun. 2008 Jan;76(1):426-36
17923514
J Immunol. 2001 Apr 1;166(7):4525-33
11254709
PLoS Pathog. 2009 Apr;5(4):e1000392
19381260
Infect Immun. 2002 Feb;70(2):869-77
11796622
J Immunol. 2007 Dec 15;179(12):8287-96
18056373
J Immunol. 2005 Feb 15;174(4):2174-84
15699149
PLoS Pathog. 2010 Feb 26;6(2):e1000789
20195465
J Exp Med. 1993 Dec 1;178(6):2249-54
7504064
Science. 2002 Mar 22;295(5563):2255-8
11910108
J Immunol. 1996 Feb 15;156(4):1469-75
8568249
J Immunol. 1999 Feb 15;162(4):2204-16
9973496
Blood. 2003 Apr 1;101(7):2521-8
12468436
Methods. 2001 Dec;25(4):402-8
11846609
J Virol. 2001 Sep;75(18):8690-6
11507214
Appl Environ Microbiol. 2002 Mar;68(3):1351-7
11872487
J Exp Med. 1995 Jul 1;182(1):21-31
7540651
Am Rev Respir Dis. 1993 Nov;148(5):1292-7
7902049